Atrial Fibrillation: the Most Common Arrhythmia

Overview

Journal Tex Heart Inst J

Specialty Cardiology & Vascular Diseases

Date 2000 Nov 28

PMID 11093410

Citations 60

Authors

C R Wyndham

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation is the most common sustained arrhythmia, increases with age, and presents with a wide spectrum of symptoms and severity Paroxysmal, persistent, and permanent forms require very individualized approaches to management. New information about electrical and anatomic remodeling emphasizes the importance of time-related thrombogenicity and progressive interference with mechanical function of the atria and ventricles. The most important aspect of diagnosis is risk stratification with respect to risk of thromboembolism. The general goals in treatment are, in order of importance: prevention of thromboemboli, control of ventricular response, restoration of sinus rhythm, and maintenance of sinus rhythm by preventing recurrences. This review focuses on the above issues. The therapeutic choices are discussed under each category Antiarrhythmic drugs, radiofrequency ablation techniques, and device therapy are reviewed with respect to prevention of recurrent atrial fibrillation.

Citing Articles

Comparative analysis of left atrial size and appendage morphology in paroxysmal and persistent atrial fibrillation patients.

Pongratz J, Riess L, Hartl S, Brueck B, Tesche C, Olbrich D J Arrhythm. 2025; 41(1):e13224.

PMID: 39866187 PMC: 11757276. DOI: 10.1002/joa3.13224.

The Efficacy and Safety of Radio Electric Asymmetric Conveyer (REAC) External Radio Electric Reprogramming for Atrial Fibrillation (EX-RER AF) Treatment: Results From a Post-market Clinical Follow-Up.

Rinaldi S, Fontani V Cureus. 2024; 16(12):e76057.

PMID: 39711944 PMC: 11659904. DOI: 10.7759/cureus.76057.

Dietary interventions in the management of atrial fibrillation.

Nabil M, Rychlik L, Nicholson A, Cheung P, Olsovsky G, Molden J Front Cardiovasc Med. 2024; 11:1418059.

PMID: 39149585 PMC: 11324562. DOI: 10.3389/fcvm.2024.1418059.

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation.

Antoun I, Li X, Kotb A, Barker J, Mavilakandy A, Koev I Front Cardiovasc Med. 2024; 11:1417029.

PMID: 39119182 PMC: 11306046. DOI: 10.3389/fcvm.2024.1417029.

Does Atrial Fibrillation at Diagnosis Change Prognosis in Patients with Aortic Stenosis?.

Petrovic O, Vidanovic S, Jovanovic I, Paunovic I, Rakocevic I, Milasinovic D J Clin Med. 2024; 13(13).

PMID: 38999483 PMC: 11242714. DOI: 10.3390/jcm13133917.

References

Garg A, Finneran W, Mollerus M, FUJIMURA O, Tone L, Feld G . Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol. 1999; 10(6):763-71. DOI: 10.1111/j.1540-8167.1999.tb00255.x. View

Paydak H, Kall J, Burke M, Rubenstein D, Kopp D, Verdino R . Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation. 1998; 98(4):315-22. DOI: 10.1161/01.cir.98.4.315. View

Ganz L, Antman E . Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1997; 8(10):1175-89. DOI: 10.1111/j.1540-8167.1997.tb01005.x. View

Ho S, Sanchez-Quintana D, Cabrera J, Anderson R . Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999; 10(11):1525-33. DOI: 10.1111/j.1540-8167.1999.tb00211.x. View

Cox J, Schuessler R, Lappas D, BOINEAU J . An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg. 1996; 224(3):267-73; discussion 273-5. PMC: 1235364. DOI: 10.1097/00000658-199609000-00003. View

Delfaut P, Saksena S, Prakash A, Krol R . Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol. 1998; 32(7):1900-8. DOI: 10.1016/s0735-1097(98)00489-6. View

Anselme F, Saoudi N, Poty H, Douillet R, Cribier A . Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation. 1999; 99(4):534-40. DOI: 10.1161/01.cir.99.4.534. View

Stambler B, Wood M, Ellenbogen K, Perry K, Wakefield L, VanderLugt J . Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. 1996; 94(7):1613-21. DOI: 10.1161/01.cir.94.7.1613. View

Yu W, Chen S, Tai C, Feng A, Chang M . Effects of different atrial pacing modes on atrial electrophysiology: implicating the mechanism of biatrial pacing in prevention of atrial fibrillation. Circulation. 1997; 96(9):2992-6. DOI: 10.1161/01.cir.96.9.2992. View

10.

Gomes J, Mehta D, Langan N, Marx S, Nayak H . Uncommon atrial flutter: characteristics, mechanisms, and results of ablative therapy. Pacing Clin Electrophysiol. 1998; 21(11 Pt 1):2029-42. DOI: 10.1111/j.1540-8159.1998.tb01121.x. View

11.

Huang D, Monahan K, Zimetbaum P, Papageorgiou P, Epstein L, Josephson M . Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1998; 9(5):462-9. DOI: 10.1111/j.1540-8167.1998.tb01837.x. View

12.

Yue L, Feng J, Gaspo R, Li G, Wang Z, Nattel S . Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997; 81(4):512-25. DOI: 10.1161/01.res.81.4.512. View

13.

Williamson B, Man K, Daoud E, Niebauer M, Strickberger S, Morady F . Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med. 1994; 331(14):910-7. DOI: 10.1056/NEJM199410063311404. View

14.

Zabalgoitia M, Halperin J, Pearce L, Blackshear J, Asinger R, Hart R . Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998; 31(7):1622-6. DOI: 10.1016/s0735-1097(98)00146-6. View

15.

Shah D, Haissaguerre M, Jais P, Takahashi A, Hocini M, Clementy J . High-density mapping of activation through an incomplete isthmus ablation line. Circulation. 1999; 99(2):211-5. DOI: 10.1161/01.cir.99.2.211. View

16.

Tse H, Lau C, Yu C, Lee K, Michaud G, Knight B . Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol. 1999; 10(9):1200-9. DOI: 10.1111/j.1540-8167.1999.tb00296.x. View

17.

Padeletti L, Porciani M, Michelucci A, Colella A, Ticci P, Vena S . Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol. 1999; 3(1):35-43. DOI: 10.1023/a:1009867305678. View

18.

Jais P, Shah D, Takahashi A, Hocini M, Haissaguerre M, Clementy J . Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1998; 21(11 Pt 2):2533-8. DOI: 10.1111/j.1540-8159.1998.tb01214.x. View

19.

Fitts S, Hill M, Mehra R, Friedman P, Hammill S, Kay G . Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. J Interv Card Electrophysiol. 1998; 2(2):139-44. DOI: 10.1023/a:1009799431363. View

20.

Sankar N, Farnsworth A . Left atrial reduction for chronic atrial fibrillation associated with mitral valve disease. Ann Thorac Surg. 1998; 66(1):254-6. DOI: 10.1016/s0003-4975(98)00281-1. View